Page last updated: 2024-10-26

etodolac and Spondylitis, Ankylosing

etodolac has been researched along with Spondylitis, Ankylosing in 4 studies

Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.

Spondylitis, Ankylosing: A chronic inflammatory condition affecting the axial joints, such as the SACROILIAC JOINT and other intervertebral or costovertebral joints. It occurs predominantly in young males and is characterized by pain and stiffness of joints (ANKYLOSIS) with inflammation at tendon insertions.

Research Excerpts

ExcerptRelevanceReference
"Etodolac is a new nonsteroidal anti-inflammatory drug (NSAID) with potent analgesic and antiarthritic properties."2.67An overview of the efficacy of etodolac in arthritic disorders. ( Bacon, PA, 1990)
" A total of 1276 adverse reactions (AR) were reported during the study, and fewer than half of these were related to study treatment."2.67Large-scale open trials with etodolac (Lodine) in France: an assessment of safety. ( Benhamou, CL, 1990)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Slobodin, G1
Rosner, I1
Santra, G1
Sarkar, RN1
Phaujdar, S1
Banerjee, S1
Siddhanta, S1
Bacon, PA1
Benhamou, CL1

Trials

2 trials available for etodolac and Spondylitis, Ankylosing

ArticleYear
An overview of the efficacy of etodolac in arthritic disorders.
    European journal of rheumatology and inflammation, 1990, Volume: 10, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Rheumatoid;

1990
Large-scale open trials with etodolac (Lodine) in France: an assessment of safety.
    Rheumatology international, 1990, Volume: 10 Suppl

    Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Dose-Response Rel

1990

Other Studies

2 other studies available for etodolac and Spondylitis, Ankylosing

ArticleYear
Indemonstrable axial spondyloarthritis: does it exist?
    The Israel Medical Association journal : IMAJ, 2013, Volume: 15, Issue:12

    Topics: Adalimumab; Adult; Amitriptyline; Analgesics, Non-Narcotic; Antibodies, Monoclonal, Humanized; Arthr

2013
Assessment of the efficacy of pamidronate in ankylosing spondylitis: an open prospective trial.
    Singapore medical journal, 2010, Volume: 51, Issue:11

    Topics: Adolescent; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Blood Sediment

2010